Cameroon Mobile Phone SMS Trial (CAMPS)

September 7, 2011 updated by: Lawrence Mbuagbaw, Yaounde Central Hospital

Improving Adherence to HAART Using Mobile Phone Text Messages

The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Centre
      • Yaounde, Centre, Cameroon
        • Yaounde Central Hospital Accredited Treatment Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • On HAART for at least 1 month
  • 21 years or more
  • Owns a mobile phone
  • Can read text messages

Exclusion Criteria:

  • On HAART for less than 1 month
  • Aged less than 21 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mobile phone text message
Weekly message with motivational content
Other Names:
  • SMS
  • Text message
  • Texto
Active Comparator: No Mobile phone text message
Usual care provided at clinic
Usual care provided at clinic
Other Names:
  • Routine care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence
Time Frame: Change from baseline at 6 months
Measured using the Visual Analogue Scale, Self Report and Pharmacy Refill Data
Change from baseline at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality
Time Frame: 6 months
All cause mortality
6 months
Weight
Time Frame: Change from baseline at 6 months
Change from baseline at 6 months
Body Mass Index
Time Frame: Change from baseline at 6 months
Change from baseline at 6 months
CDC classification
Time Frame: Change from baseline at 6 months
Change from baseline at 6 months
WHO Classification
Time Frame: Change from baseline at 6 months
Change from baseline at 6 months
CD4 count
Time Frame: Change from baseline at 6 months
Change from baseline at 6 months
Viral load
Time Frame: Change from baseline at 6 months
Change from baseline at 6 months
Quality of life
Time Frame: Change from baseline at 6 months
Measured using the SF-12 quality of life form
Change from baseline at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lawrence Mbuagbaw, MD, MPH, Centre for the Development of Best Practices in Health
  • Study Director: Pierre Ongolo-Zogo, MD, BSc, Centre for the Development of Best Practices in Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2010

Primary Completion (Actual)

July 1, 2011

Study Completion (Actual)

July 1, 2011

Study Registration Dates

First Submitted

November 22, 2010

First Submitted That Met QC Criteria

November 23, 2010

First Posted (Estimate)

November 24, 2010

Study Record Updates

Last Update Posted (Estimate)

September 8, 2011

Last Update Submitted That Met QC Criteria

September 7, 2011

Last Verified

September 1, 2011

More Information

Terms related to this study

Other Study ID Numbers

  • CAMPS
  • PACTR201011000261458 (Registry Identifier: Pan-African Clinical Trials Registry)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV

Clinical Trials on Mobile phone text message

3
Subscribe